Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger ZZ-type and EF-hand domain-containing protein 1 (ZZEF1) is a multidomain protein characterized by the presence of ZZ-type zinc finger and EF-hand motifs. It functions primarily as a histone H3 reader, binding to the N-terminus of histone H3 and recognizing various epigenetic modifications on the H3 tail. ZZEF1 serves as a transcriptional coregulator, particularly by interacting with Krüppel-like factors KLF6 and KLF9 and modulating the expression of their target genes. The protein is implicated in chromatin organization, transcriptional regulation, and possibly neuronal and visual processes. Mutations in ZZEF1 have been associated in the literature with diseases such as diabetes and certain cancers, but it is not currently considered a direct therapeutic target such as a receptor, enzyme, or transporter
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger ZZ-type and EF-hand domain-containing protein 1 (ZZEF1).